Provided by Tiger Trade Technology Pte. Ltd.

Immunocore Holdings plc

29.91
-0.1300-0.43%
Volume:277.56K
Turnover:8.32M
Market Cap:1.51B
PE:-42.40
High:30.83
Open:30.19
Low:29.52
Close:30.04
52wk High:40.71
52wk Low:23.15
Shares:50.53M
Float Shares:37.57M
Volume Ratio:0.87
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7054
EPS(LYR):-0.7054
ROE:-9.58%
ROA:-1.54%
PB:3.97
PE(LYR):-42.40

Loading ...

Immunocore to present five-year overall survival data for KIMMTRAK at AACR meeting

Reuters
·
Mar 18

Immunocore Holdings Cut to Hold From Buy by Jefferies

Dow Jones
·
Mar 16

Will Immunocore's (IMCR) 2025 Revenue Growth and Narrower Loss Reshape Its Investment Narrative?

Simply Wall St.
·
Mar 10

Immunocore to present at upcoming investor conferences

Reuters
·
Mar 03

Immunocore Holdings (IMCR) Gets a Hold from Mizuho Securities

TIPRANKS
·
Feb 26

Immunocore Holdings Is Maintained at Buy by Needham

Dow Jones
·
Feb 26

Stock Track | Immunocore Holdings Plummets 5.02% Intraday After Q4 Earnings Miss and Moderating 2026 Growth Outlook

Stock Track
·
Feb 26

Immunocore Holdings plc Publishes Corporate Presentation on Bispecific Soluble TCR Immunotherapies Across Oncology, Infectious Diseases and Autoimmune Disease

Reuters
·
Feb 26

Immunocore Holdings PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 25

UK's Immunocore Q4 KIMMTRAK sales rise 24%

Reuters
·
Feb 25

Immunocore Hldgs Q4 EPS $(0.60) Misses $(0.23) Estimate, Sales $104.478M Miss $107.310M Estimate

Benzinga
·
Feb 25

Earnings Flash (IMCR) Immunocore Posts Q4 Loss $0.60 a Share

MT Newswires Live
·
Feb 25

Immunocore Q4 net sales rise 24% to USD 104.5 million

Reuters
·
Feb 25

Immunocore - Reports Q4 2025 Diluted Loss per Share $0.60

THOMSON REUTERS
·
Feb 25

Immunocore : Expect Moderating Revenue Growth in 2026

THOMSON REUTERS
·
Feb 25

Immunocore FY EPS USD -0.71 VS. Ibes Estimate USD -0.34

THOMSON REUTERS
·
Feb 25

Immunocore FY Net Income USD -35.514 Million VS. Ibes Estimate USD -18.3 Million

THOMSON REUTERS
·
Feb 25

Immunocore - Kimmtrak Q4 Sales $104.5 Mln, Full Year $400 Mln

THOMSON REUTERS
·
Feb 25

Press Release: Immunocore reports fourth quarter and full year 2025 financial results and provides a business update

Dow Jones
·
Feb 25

Immunocore Holdings PLC expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
Feb 23